Celgene (CELG) Affirms $600M Acquisition of EngMab - Bloomberg, Citing Statement

September 30, 2016 12:37 PM EDT

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Celgene (Nasdaq: CELG) affirms earlier reports that it acquired EngMab for $600 million, according to Bloomberg, citing an emailed statement on Friday.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Mergers and Acquisitions

Add Your Comment